1 |
Abp 959 - biosimilar to eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
2 |
Abp 959 - proposed biosimilar to eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
3 |
Eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 8件: 11, 13, 14, 61, 62, 109, 222, 223 💬 |
4 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
5 |
Other: eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
109 1件: 109 💬 |
6 |
Sb12 (proposed eculizumab biosimilar) |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
7 |
Soliris |
- |
- |
- |
- |
011 7件: 11, 13, 14, 61, 62, 109, 222 💬 |
8 |
Soliris (eculizumab) |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
9 |
Soliris (r) |
- |
- |
- |
- |
061 1件: 61 💬 |
10 |
Soliris - 300 mg concentrato per soluzione per infusione - uso endovenoso 1 flaconcino (vetro) 30 ml (10 mg/ml) |
- |
- |
- |
- |
109 1件: 109 💬 |
11 |
Soliris 300 |
- |
- |
- |
- |
062 1件: 62 💬 |
12 |
Soliris 300 mg concentrado para solución para perfusión |
- |
- |
- |
- |
109 1件: 109 💬 |
13 |
Soliris® |
- |
- |
- |
- |
062 1件: 62 💬 |